Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany
European Journal of Cancer · 2025-09 · 227 · 115621
DOI: 10.1016/j.ejca.2025.115621 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2025-09. Verfasst von Constantin Rieger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany. Electronic addres…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany. Electronic address: constantin.rieger@uk-koeln.de.
- Faculty of Law, Business and Economics, University of Bayreuth, Bayreuth, Germany.
- Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.
- Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany; Department of Urology, University Hospital of Zurich, Zurich, Switzerland.
- Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany; Department of Urology, Medical University Vienna, Austria.
Zitieren
APA
Rieger, C., Schlüchtermann, J., Heidenreich, J., Steenbock, O., Schmid, F. A., Weiten, R., Bach, C., Pfister, D., & Heidenreich, A. (2025). Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany. European Journal of Cancer, 227, 115621. https://doi.org/10.1016/j.ejca.2025.115621
Vancouver
Rieger C, Schlüchtermann J, Heidenreich J, Steenbock O, Schmid FA, Weiten R, et al. Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany. European Journal of Cancer. 2025;227:115621. doi:10.1016/j.ejca.2025.115621
BibTeX
@article{Rieger2025,
author = {Rieger, Constantin and Schlüchtermann, Jörg and Heidenreich, Julian and Steenbock, Olivia and Schmid, Florian A and Weiten, Richard and Bach, Christian and Pfister, David and Heidenreich, Axel},
title = {Cost-effectiveness analysis of perioperative durvalumab plus platin-based chemotherapy in muscle invasive bladder cancer in Germany},
journal = {European Journal of Cancer},
year = {2025},
volume = {227},
pages = {115621},
doi = {10.1016/j.ejca.2025.115621}
}
EUVIMED